ArticleFrontiers in immunology2022

Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses.

Yidan Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.